Articles

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial

Department of Hematology, University Hospitals Leuven and KU Leuven, Belgium;Academic Centre for Nursing and Midwifery, KU Leuven, Belgium
Department of Hematology, University Hospitals Leuven and KU Leuven, Belgium
IT Department, University Hospitals Leuven, KU Leuven, Belgium
L-BioStat, KU Leuven – University of Leuven & Universiteit Hasselt, Leuven, Belgium
Academic Centre for Nursing and Midwifery, KU Leuven, Belgium;Institute of Nursing Science, Department Public Health, University of Basel, Switzerland
Experimental Transplantation and Immunology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA
University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Department of Hematology and Clinical Oncology, University of Regensburg, Germany
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Division of Hematology, Medical University of Graz, Austria
ICO/Hospital Duran I Reynals, Hospitalet De Llobregat, Spain
Cliniques Universitaires Saint-Luc, Brussels, Belgium
Department of Hematology, AZ Sint-Jan Brugge, Belgium
Institut Jules Bordet - Université Libre de Bruxelles, Belgium
Hematology and Stem Cell Transplantation, Ghent University Hospital, Belgium
Université Catholique de Louvain, CHU UCL Namur (Godinne site), Yvoir, Belgium
Hematology, University of Liège, GIGA-I3, Belgium
Department of Hematology, University Hospitals Leuven and KU Leuven, Belgium
Academic Centre for Nursing and Midwifery, KU Leuven, Belgium
Vol. 103 No. 10 (2018): October, 2018 https://doi.org/10.3324/haematol.2018.190777